BCYC
Price
$8.75
Change
+$0.71 (+8.83%)
Updated
Jul 18, 01:45 PM (EDT)
Capitalization
556.8M
13 days until earnings call
STRO
Price
$0.76
Change
-$0.01 (-1.30%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
64.69M
20 days until earnings call
Interact to see
Advertisement

BCYC vs STRO

Header iconBCYC vs STRO Comparison
Open Charts BCYC vs STROBanner chart's image
Bicycle Therapeutics
Price$8.75
Change+$0.71 (+8.83%)
Volume$4.73K
Capitalization556.8M
Sutro Biopharma
Price$0.76
Change-$0.01 (-1.30%)
Volume$934
Capitalization64.69M
BCYC vs STRO Comparison Chart in %
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. STRO commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and STRO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (BCYC: $8.04 vs. STRO: $0.77)
Brand notoriety: BCYC and STRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 120% vs. STRO: 49%
Market capitalization -- BCYC: $556.8M vs. STRO: $64.69M
BCYC [@Biotechnology] is valued at $556.8M. STRO’s [@Biotechnology] market capitalization is $64.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileSTRO’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • STRO’s FA Score: 1 green, 4 red.
According to our system of comparison, both BCYC and STRO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish while STRO’s TA Score has 6 bullish TA indicator(s).

  • BCYC’s TA Score: 5 bullish, 5 bearish.
  • STRO’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, STRO is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а -0.62% price change this week, while STRO (@Biotechnology) price change was -6.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.34%. For the same industry, the average monthly price growth was +13.98%, and the average quarterly price growth was +35.38%.

Reported Earning Dates

BCYC is expected to report earnings on Oct 30, 2025.

STRO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+3.34% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($557M) has a higher market cap than STRO($64.7M). BCYC YTD gains are higher at: -42.571 vs. STRO (-58.375). BCYC (-200.61M) and STRO (-203.18M) have comparable annual earnings (EBITDA) . BCYC has more cash in the bank: 793M vs. STRO (249M). BCYC has less debt than STRO: BCYC (8.33M) vs STRO (21.4M). STRO has higher revenues than BCYC: STRO (66.4M) vs BCYC (25.7M).
BCYCSTROBCYC / STRO
Capitalization557M64.7M861%
EBITDA-200.61M-203.18M99%
Gain YTD-42.571-58.37573%
P/E RatioN/AN/A-
Revenue25.7M66.4M39%
Total Cash793M249M318%
Total Debt8.33M21.4M39%
FUNDAMENTALS RATINGS
BCYC vs STRO: Fundamental Ratings
BCYC
STRO
OUTLOOK RATING
1..100
152
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
1975

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCYC's Valuation (20) in the null industry is in the same range as STRO (26) in the Pharmaceuticals Major industry. This means that BCYC’s stock grew similarly to STRO’s over the last 12 months.

BCYC's Profit vs Risk Rating (100) in the null industry is in the same range as STRO (100) in the Pharmaceuticals Major industry. This means that BCYC’s stock grew similarly to STRO’s over the last 12 months.

BCYC's SMR Rating (96) in the null industry is in the same range as STRO (100) in the Pharmaceuticals Major industry. This means that BCYC’s stock grew similarly to STRO’s over the last 12 months.

BCYC's Price Growth Rating (65) in the null industry is in the same range as STRO (65) in the Pharmaceuticals Major industry. This means that BCYC’s stock grew similarly to STRO’s over the last 12 months.

BCYC's P/E Growth Rating (100) in the null industry is in the same range as STRO (100) in the Pharmaceuticals Major industry. This means that BCYC’s stock grew similarly to STRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCYCSTRO
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TELIF0.260.01
+4.16%
TELESCOPE INNOVATIONS CORP.
IAUGF5.52N/A
N/A
Insurance Australia Group Ltd.
MCOIF6.61N/A
N/A
MultiChoice Group Limited
NMBF15.75N/A
N/A
NMB Finl. Corp
MLXEF0.42-0.01
-2.91%
Metals X, Ltd.

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+3.34%
XNCR - BCYC
54%
Loosely correlated
+2.72%
RPTX - BCYC
51%
Loosely correlated
+6.29%
RLAY - BCYC
50%
Loosely correlated
+0.27%
INO - BCYC
48%
Loosely correlated
+2.24%
RCUS - BCYC
45%
Loosely correlated
+1.73%
More